cti-mcpFinanceResearch & Datahjsh200219AlicenseAqualityDmaintenanceEnables to analyze Korean pharma/biotech stocks using clinical trial data from ClinicalTrials.gov and market data from Naver Finance, providing 100-point scoring, decision labels, and technical indicators. Updated 6 months ago (2026-05-01 18:18 UTC)10MIT